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Angioedema is an abrupt swelling of the skin, mucous membrane, or both including respiratory and gastrointestinal tracts. This
study aimed to report an experience of angioedema in a university hospital with respect to etiologies, clinical features, treatment,
and outcome. One hundred and ﬁve patients were enrolled. About half had angioedema without urticaria. The common sites
of involvement were periorbital area and lips. Forty ﬁve patients (49%) had systemic symptoms. The most common cause of
angioedemawasallergicangioedema.Nonsteroidalanti-inﬂammatorydrug-inducedangioedemaandidiopathicangioedemawere
detected in 20% and 18%, respectively. Among patients with allergic angioedema, 41.7% were caused by food, 39.6% by drugs.
Thirty seven patients (39%) had recurrent attacks of angioedema. Mean standard deviation (SD) number of attacks in patients
with recurrent angioedema was 3.9 (2.7) (ranging from 2 to 10 times). Patients who had older age and multiple sites of skin
involvement had tendency to have systemic symptoms.
Copyright © 2007 Kanokvalai Kulthanan et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
1. INTRODUCTION
Angioedema is an abrupt swelling of the skin, mucous
membrane, or both including respiratory and gastrointesti-
nal tracts [1]. The swelling is nonpitting, skin-colored, or
sometimes erythematous, and shows a predilection for areas
where the skin is lax. Swellings normally subside in around
24 hours or more and resolve without discoloring the skin.
Angioedema is a consequence of local increase in perme-
ability of subcutaneous or submucosal capillaries and post-
capillary venules causing local plasma extravasation in re-
sponse to mediators such as histamine, bradykinin [2]. An-
gioedema and urticaria may coexist. Allergic angioedema
(histamine-induced angioedema) is a hypersensitivity reac-
tion to various causes such as drugs, foods, insect venoms
[1]. Kinin-induced angioedema is believed to be caused by
bradykinin-induced activation of endothelial cells resulting
in vasodilatation and capillary leakage [3]. Two diﬀerent
types of kinin-induced angioedema are known, hereditary
anddrug-inducedforms[2].However,idiopathicformswith
unknown cause and mixed forms also exist [2].
Greaves et al. classiﬁed angioedema according to the
causes, that is, allergic, nonsteroidal anti-inﬂammatory drug
(NSAID)-induced, idiopathic angioedema, angioedema as-
sociated with idiopathic or autoimmune urticaria, associ-
ated with urticarial vasculitis, infection, and infestations, an-
gioedema with eosinophilia, associated with some physical
urticarias and with cholinergic urticaria, associated with al-
lergic contact urticaria, defect in the plasma inhibitor of
the ﬁrst component of complement (C1-INH deﬁciency)-
hereditary (HAE), acquired angioedema, HAE with normal
C1-INH in women, and angiotensin-converting enzyme in-
hibitor (ACEI)-induced angioedema [4].
There were some reports of immunogenetic diﬀerences
between Oriental and Caucasian populations, resulting in
diﬀerences in the clinical presentation and frequency of au-
toantibodies detected in some autoimmune diseases [5, 6].
Moreover, diﬀerent dietary habits between Asian and West-
ern countries as well as the socioeconomic status may cause
diﬀerent allergen sensitization. Most of the studies about an-
gioedema were reported from Western countries. It is inter-
esting to know the prevalence and clinical features of Asian2 Clinical and Developmental Immunology
patients with angioedema. This study aims to report an ex-
perience of angioedema in a university hospital with respect
to etiologies, clinical features, treatment, and outcome.
2. MATERIALS AND METHODS
This study has been approved by the Siriraj Hospital insti-
tutional review board. Records of patients with angioedema
who attended the outpatient department of Siriraj Hospital
between January 2005 and December 2006 were retrospec-
tively reviewed. Patients aged at least 15 years were assigned
a diagnosis of angioedema by an attending physician by hav-
ing an abrupt and short-lived nonpitting swelling of skin in
areas such as the face, lips, oral cavity; mucous membranes
(including the respiratory and intestinal tract) or both, with-
out evidence of infectious, traumatic, or other clear causes of
the swelling.
Demographic data, etiologies, clinical features, course of
the disease, treatment, and outcome were studied. With the
exception of ACEI, a drug reaction was regarded as a likely
cause if taken within 24 hours before onset of angioedema.
All suspected drugs used were discontinued or replaced with
chemically unrelated drugs. Food intolerance was regarded
as a likely cause if angioedema occurred within 2 hours after
ingestion of suspected foods. Skin prick testing, drug provo-
cation tests, and oral food challenge tests were performed if
necessary and if the disease severity was not severe. Foods
and drugs that were subsequently tolerated after challenging
in remission period were excluded from the causes of an-
gioedema.Laboratoryinvestigationincludedcompleteblood
counts, urinalysis, erythrocyte sedimentary rate (ESR), stool
examination, and other investigations that were necessary
for the individuals, that is, BUN, creatinine, AST, ALT, ALP,
bilirubins, total protein, albumin, HbsAg, anti-HCV, free T3,
freeT4,thyroidstimulatinghormone(TSH),antithyroidau-
toantibodies, that is, antithyroglobulin, and antimicrosomal
antibodies (passive hemagglutination test; Hausen Bernstein
CO., LTD, 12076 Santa Fe Drive, Lenexa, KS 66215, USA),
antinuclear antibodies (ANA), cryoglobulins, serum com-
plement level (C4 determined by Nephelometry; Beckman,
Gagny, France; C1q measured by single radial immunodif-
fusion using monospeciﬁc antisera), chest, and sinus X-ray
studies. Other data obtained were personal history of allergic




using SPSS version 10 for Windows. The t-test and Chi-
squared test was, respectively, used for statistical analysis
among continuous and categorical data.
4. RESULTS
Onehundredandﬁvepatientswereenrolledinthestudyand
82 cases (78.1%) were female. Mean (SD) age of the patients
was 39.4 (18.4) years with an age ranged of 15 to 88 years.
Fifty ﬁve patients (52.4%) had angioedema without urticaria
(Table 1). Forty ﬁve patients (49%) had systemic symptoms.
Average duration of individual lesion of angioedema was
41.9 hours with a range of 24 to 168 hours. Two thirds of
the patients were presented with the ﬁrst episode. Mean age
of the ﬁrst attack was 38.2 years. One fourth of the patients
had personal history of atopy, the most common of which
was allergic rhinitis.
Patients with systemic symptoms had statistically signiﬁ-
cant higher mean age (44.2 versus 35.8 years, P = .032) and
multiple sites of angioedema (P = .001) than those without
systemic symptoms.
Table 2 shows signs and symptoms in various groups of
angioedema. Two thirds of the patients stated itching as a
symptom. However, the group of angioedema with urticaria
had statistically signiﬁcant higher proportion of itchy sensa-
tion than those without urticaria (P<. 001). Among cases
who had systemic symptoms, the common sign and symp-
tomwerechestdiscomfortand/ordyspnea.Only9of105pa-
tients (8.6%) had hypotension. Seven of these 9 patients had
the ﬁrst attack of angioedema. Five of them had angioedema
withurticaria.Allofthemalsohadothersystemicsymptoms.
Concerning the causes, 2 cases had angioedema from insect
stings,2casesfromfoodreactions,1casefromNSAID,1case
from amoxicillin, the others from unspeciﬁed causes.
Table 3 shows anatomical sites of involvement of an-
gioedema. Overall, the common sites of involvement were
periorbital area and lips. There were no statistically signiﬁ-
cant diﬀerences in anatomical site involvement between the
group with or without urticaria. In this study, only one pa-
tient had angioedema on her lips caused by ACEI (perindo-
pril). Patients with NSAID-induced angioedema had perior-
bital swelling in 95.2%; lip swelling, 14.3%; tongue swelling,
4.8%; and swelling of extremities, 4.8%, and tended to have
higher percentage of periorbital swelling compared with al-
lergic angioedema group (95.2% versus 68.8%, P<. 05).
The group with allergic angioedema was more likely to have
lip swelling when compared with the group with NSAID-
induced angioedema (43.8% versus 14.3%, P<. 05) (data
not shown).
Table 4 shows presumed causes of angioedema in this
study. The most common cause was allergic angioedema.
Nonsteroidal anti-inﬂammatory drug- (NSAID-) induced
angioedema and idiopathic angioedema were detected in
20% and 18%, respectively. NSAIDs responsible for an-
gioedema in our study were ibuprofen (57%), aspirin (19%),
diclofenac(9.5%),mefenamicacid(4.8%),naproxen(4.8%),
and meloxicam (4.8%). Among 48 patients with allergic an-
gioedema, 41.7% cases were caused by food, 39.6% by drugs,
4 patients (8.3%) by insects (2 cases by ﬁreant, 2 cases by
unknown insects), and 5 patients (10.4%) were aﬀected by
aeroallergens. The most common food that induced an-
gioedema was seafood (70%). The common drugs that pre-
sumed to be the causes of angioedema were antibiotics (12
out of 19 cases; 63.2%), the most common was amoxicillin
(3 in 12 cases; 25%).
Among 48 patients with allergic angioedema, personal
history of atopy was found in 12 patients (25%) (allergic
rhinitis 10 cases, 20.8%; asthma 4 cases, 8.3%). Seven of
21 patients (33.3%) with NSAID-induced angioedema hadKanokvalai Kulthanan et al. 3
Table 1: Demographic data in various group of angioedema.
Characteristics Angioedema Angioedema without Angioedema with Angioedema with systemic
total (n = 105) urticaria (n = 55) urticaria (n = 50) symptoms (n = 45)
Sex:N u m b e r( % )
Male 23 (21.9) 13 (23.6) 10 (20) 9 (20)
Female 82 (78.1) 42 (76.4) 40 (80) 36 (80)
Age, years: mean (SD) 39.4 (18.4) 40.5 (18.5) 38.3 (18.3) 44.2 (20.9)∗
Duration of individual lesion, hours: mean (SD) 41.9 (40.7) 43.5 (40) 39.8 (43.2) 45.9 (47.6)
Age of onset of ﬁrst attack, years: mean (SD) 38.2 (18.5) 39.2 (19.4) 37.3 (17.7) 42.4 (21.7)
Number of attack: mean (SD) 3.9 (2.7) 3.9 (2.6) 3.7 (3.2) 3.3 (2.1)
Personal atopic history: number (%) 25 (25.3) 17 (33.3) 8 (16.7) 13 (30.2)
Allergic rhinitis 19 (19.2) 14 (27.5) 5 (10.4) 9 (20.9)
Allergic conjunctivitis 4 (4) 3 (5.9) 1 (2.1) 1 (2.3)
Asthma 13 (13.1) 7 (13.7) 6 (12.5) 7 (16.3)
Atopic dermatitis 1 (1) 0 1 (2.1) 1 (2.3)
∗P<. 05.
Table 2: Signs and symptoms associated with angioedema.
Symptoms, number (%) Angioedema Angioedema without Angioedema with Angioedema with systemic
total (n = 105) urticaria (n = 55) urticaria (n = 50) symptoms (n = 45)
Urticaria 50 (47.6) 0 50 (100) 17 (37.8)
Itchy skin 62 (59) 18 (32.7)∗ 44 (88) 25 (55.6)
Pain 7 (6.7) 3 (5.5) 4 (8) 4 (8.9)
Stuﬀed nose 8 (7.6) 5 (9.1) 3 (6) 6 (13.3)
Systemic symptoms 45 (42.9) 28 (50.9) 17 (34) 45 (100)
Fainting 6 (5.7) 1 (1.8) 5 (10) 6 (13.3)
Unconciousness 1 (1) 0 1 (2) 1 (2.2)
Dyspnea/wheeze 42 (40) 26 (47.3) 16 (32) 42 (93.3)
Abdominal pain 4 (3.8) 2 (3.6) 2 (4) 4 (8.9)
Hypotension 9(8.6) 4(7.3) 5(10) 9(20)
∗P<. 001.
atopichistories(allergicrhinitis4cases,19%;asthma6cases,
28.5%). None in idiopathic angioedema group had history
of atopy. Six of 20 patients (30%) who had reactions to foods
had atopic histories (allergic rhinitis 5 cases, 25%; asthma 1
case, 5%).
Acquired C1-INH deﬁciency was presumed to be the
cause of angioedema in 4 patients (3.8%) who were diag-
nosed and fulﬁll criteria of systemic lupus erythematosus
(SLE).AllpatientshaddecreasedlevelofC4andC1qandhad
no other explanations for the causes of their angioedema.
However, it was not conﬁrmed by special serologic testing
for C1-INH levels. Among patients who had angioedema as-
sociated with contact urticaria, the responsible agents were
hair dye, face cleansing foam, herb, and corrosive agent used
in tin cleansing. Two patients had upper respiratory tract in-
fection simultaneously with angioedema.
With exception of patients with C1-INH deﬁciency, 90
patients (90%) were treated with antihistamine. Other med-
ications included corticosteroids (71%), adrenaline (24%),
H2 blocker (20%), and proton pump inhibitor (3%). Fifteen
percent of the patients received intravenous ﬂuid replace-
ment and thirteen percent received oxygen therapy. How-
ever, no patients needed emergency intubation. Drugs sus-
pected to be the cause of angioedema had been discontin-
uedinallcases.PatientswithacquiredC1-INHdeﬁciencyre-
ceived prednisolone treatment for the underlying LE disease
as well as prophylactic androgenic compounds. One patient
withHAEreceiveddanazolasaprophylacticmedicationwith
agoodresponse.Hehadaprevioushistoryofemergencytra-
cheostomy in the rural hospital.
Two thirds of the patients had their ﬁrst visit at the emer-
gency department. However, only three percent of the pa-
tients were admitted as inpatient. No patients in the present
study died as a result of angioedema. Thirty seven patients
(39%) had recurrent attacks of angioedema. Mean (SD)
numberofattacksinpatientswithrecurrentangioedemawas
3.9 (2.7) (ranging from 2–10 times).
5. DISCUSSION
Most patients with angioedema in this study were female.
This is similar to the study of Cohen et al. which 63% of their
patients were female [7]. However, male predominance has
also been reported [8, 9].4 Clinical and Developmental Immunology
Table 3: Anatomic sites of involvement of angioedema.
Site of edema, number (%) Angioedema Angioedema without Angioedema with Angioedema with systemic
total (n = 105) urticaria (n = 55) urticaria (n = 50) symptoms (n = 45)
Face 101 (96.2) 53 (96.4) 48 (96) 45 (100)
Periorbital 70 (66.7) 41 (74.5) 29 (58) 37 (82.2)
Lip 43 (41) 19 (34.5) 24 (48) 21 (46.7)
Tongue 3 (2.9) 2 (3.6) 1 (2) 1 (2.2)
Glottis 7 (6.7) 4 (7.3) 3 (6) 7 (15.6)
Genitalia 1( 1 ) 1( 1 ) 0( 0 ) 0( 0 )
Extremities 11 (10.5) 3 (5.5) 8 (16) 5 (11.1)
Multiple sites 31 (29.5) 14 (25.5) 17 (34) 22 (48.9)
Table 4: Presumed causes of angioedema in 105 patients in this study.
Causes Number (%)
Allergic angioedema∗ 48 (45.7)
NSAID-induced angioedema 21 (20)
Idiopathic angioedema 19 (18.1)
Associated with contact urticaria 4 (3.8)
Acquired C’1 INH deﬁciency 4 (3.8)
Associated with chronic idiopathic or autoimmune chronic urticaria 3 (2.9)
Associated with urticarial vasculitis 2 (1.9)
Infection and infestations 2 (1.9)
Angiotensin-converting enzyme inhibitor-induced angioedema 1 (1)
Hereditary angioedema (C’1 INH deﬁciency) 1 (1)
Associated with physical urticarias 0
∗Angioedema occurring within 1 to 2 hours of exposure to the oﬀending allergen, caused by immediate type
hypersensitivity reaction.
In 2002, Vichyanond et al. reported the prevalence of al-
lergic rhinitis; and asthma in Thai university students was
26.3% and 8.8%, respectively, [10]. In the present study, the
personal history of allergic rhinitis and asthma in patients
with angioedema were 19.2% and 13.1%, respectively. When
compared with the prevalence from Vichyanond et al., there
were no statistically signiﬁcant increases in the prevalence of
allergic rhinitis and asthma in our patients with angioedema
and various subgroups of angioedema (allergic angioedema,
idiopathicandfood-induced)exceptforNSAID-inducedan-
gioedema group which had statistically signiﬁcant higher
prevalence of asthma (P = .012).
Acute allergic angioedema is usually accompanied by ur-
ticaria [1]. Allergic reactions to food, drugs, environmental
contacts, insect stings, and other substances can cause IgE-
mediated immediate hypersensitivity reaction. Systemic re-
lease of histamine and other mediators from mast cells may
cause angioedema, either isolated or as a part of systemic
anaphylaxis. It usually occurs within 1 to 2 hours of exposure
to the responsible allergen. Its onset is reliant on prior sensi-
tizingexposure.Allergicangioedemaismorecommoninpa-
tients with atopy, that is, allergic rhinitis, asthma, and atopic
dermatitis. However, allergic reactions to foods or medica-
tions may be seen in the absence of diseases associated with
atopy; and some medications such as radiocontrast media
and opiates can cause nonimmunologic mast cell degranula-
tion. Similar to acute urticaria, diagnosis of the cause of an-
gioedema depends principally on the history. Most patients
are fully aware of the association of allergens or drugs with
the onset of acute angioedema. Skin prick testing and ra-
dioallergosorbent serum testing, which demonstrate the spe-
ciﬁc IgE-mediated hypersensitivity, may provide supportive
information in some instances [1].
In our study, 21 of 48 patients (43.8%) with allergic
angioedema had urticarial wheals accompanied with an-
gioedema. About half of patients who had personal histories
of atopy had allergic angioedema. The common causes of al-
lergic angioedema in this study were foods (mostly seafood),
anddrugs(otherthanNSAIDs).Itshouldbenotedthatpeni-
cillin is less commonly used in our country nowadays.
IgE-andmastcell-mediatedreactionsleadingtourticaria
and angioedema can be caused by physical stimuli such as
cold urticaria. In this study, besides contact urticaria and an-
gioedema, no patients had symptoms caused by other physi-
cal stimuli.
Because of the increasing of ACEI use in this era, many
studies reported an increase in ACEI-induced angioedema
which had been reported to occur in 0.1–0.5% of patients
taking these drugs [11]. Megerian et al. reported that be-
tween 1985 and 1990, 35% of patients presenting with an-
gioedema were using ACEI [12]. Pigman et al. reported
that 24% of angioedema cases presenting to an emergencyKanokvalai Kulthanan et al. 5
department between 1984 and 1991 were associated with
ACEI use [8]. Cohen et al. reported a 5-year study conducted
in a large, urban, university hospital between 1994 and 1998
[7]. Fifty eight percent of their patients with angioedema
were using ACEIs. In spite of the popular usage of ACEIs
in our country, only one patient (1%) in the present study
had angioedema associated with ACEI usage. Similarly, Thai
FDA report states that out of 364 cases of drug-induced an-
gioedemain2006,101patients(27.7%)hadNSAID-induced
angioedema (mostly ibuprofen, 29.7%; aspirin, 10%) and 7
patients (1.9%) had ACEI-induced angioedema. A 4-fold in-
crease in the risk of ACEI-induced angioedema had been
reported in Black-American patients, suggesting the result
of diﬀerences in the kallikrein-kinin system with increased
sensitivity to bradykinin [13]. Perhaps, this racial diﬀerence
may explain a few cases of ACEI-induced angioedema in the
present study.
In our study, NSAIDs were the second common cause
of angioedema. The most common NSAID causing an-
gioedema in this study was ibuprofen. The prevalence of
urticaria and angioedema to NSAIDs in the general popu-
lationhas been reported to be 0.1–0.3% [14, 15]. However,
in selected atopic populations, there were some reports of
increases in frequency from childhood to young adulthood
[16, 17]. A variety of NSAIDs can cause angioedema and as-
pirin reported to be the most common [1]. True allergic re-
actionstoNSAIDsarerare.Reactionstothesedrugsareoften
termed pseudoallergic reaction explained by pharmacologic
properties of the drugs that inhibit COX enzymes. Quiralte
et al. reported that that the most frequent NSAID adverse re-
action observed in the skin is facial angioedema [18].
It has also been recognized that NSAIDs can aggravate
skin lesions in up to one third of patients with active chronic
urticaria, but they do not appear to induce any eruptions
during the symptomless periods of the disease [16]. Chal-
lenges to conﬁrm the patient’s hypersensitivity to NSAIDs
identiﬁed as probable causes of previous reactions are de-
ferred, in order to avoid provoking unnecessary risks. A pa-
tient with an adverse NSAID reaction should ideally have an
alternative NSAID if necessary.
In our study, patients with NSAID-induced angioedema
had statistically signiﬁcant increased prevalence of asthma
buthadnoincreasedprevalenceofallergicrhinitisandatopic
dermatitis. All patients with NSAID-induced angioedema
hadfacialinvolvementandthemostcommonwasperiorbital
area. The group with NSAID-induced angioedema showed
statistically signiﬁcant periorbital involvement (P = .001)
when compared with other subgroups of angioedema.
Patientswithserumsicknessornecrotizingvasculitis,an-
gioedema, and urticaria are mediated by immune complex-
mediated reaction [7]. In our study, only 2 patients (1.9%)
had angioedema associated with urticarial vasculitis.
The mainstay of emergency medical treatment of HAE
is intravenous fresh frozen plasma or C1 inhibitor concen-
trate or lyophilized vapor-heated C1 inhibitor concentrate
[19, 20]. For patients in whomattacks are infrequent and not
life-threatening, the treatment may be restricted to avoid-
ance of provocative factors, that is, trauma, estrogens, and
ACEI administration [1]. However, exacerbation of HAE
can be prevented by aminocaproic acid, tranexamic acid, or
anabolic steroids such as danazol and stanozolol [21, 22].
Treatmentof acquiredC1-INH deﬁciencyrequirestreatment
of underlying disease plus treatment with afore-mentioned
drugs as that for the treatment of HAE.
Severe symptoms of other forms of angioedema may be
treated with epinephrine injection and less severe symptoms
are often controlled by antihistamine. The use of corticos-
teroids may reduce the possibility of relapse [1].
In summary, our study provided an overview of an-
gioedema based on etiological aspects and clinical features.
Patients who had older age and multiple sites of skin in-
volvement had tendency to have systemic symptoms. In con-
trast to reports from Western countries, ACEI-induced an-
gioedema was uncommonly detected in the present study.
Ibuprofen was the most common NSAID that caused an-
gioedema in this study whereas aspirin was reported to be
the most common culprit NSAID in Western countries.
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